 low-dos enoximon subject cardiac transplant clinic result effect beta-adrenerg receptor period phosphodiesteras inhibitor posit inotrop vasodil properti pretransplant patient end-stag heart failur clinic requir addit inotrop support clinic cours myocardi beta-adrenerg receptor statu explant heart patient result pretransplant patient addit inotrop support patient requir cessat enoximon advers effect exacerb ventricular arrhythmia sixty-six enoximone-tr patient underw cardiac transplant mean day day enoximon wherea patient cardiac transplant respect pretransplant surviv rate patient enoximon time list transplant control patient enoximon signific patient enoximon ventricular myocardi beta-adrenerg receptor time transplant valu ventricl pretransplant patient ventricular myocardium patient enoximon intraven beta-adrenerg agonist total beta-adrenerg receptor densiti patient enoximon enoximon intraven beta-adrenerg agonist patient intraven beta-adrenerg agonist patient enoximon myocardi beta receptor densiti respect subgroup intraven beta-adrenerg agonist isoproterenol- calcium-medi contractil respons isol right ventricular prepar patient enoximon similar valu control patient intraven beta-adrenerg agonist enoximone-rel beta-adrenerg subsensit damag contractil apparatu